Eneida R. Nemecek, M.D., M.S., M.B.A.

  • Professor of Medicine, School of Medicine
  • Professor of Pediatrics, School of Medicine
  • Medical Director for Clinical Research, OHSU Knight Cancer Institute, School of Medicine


Dr. Nemecek is involved in research to increase the understanding of pediatric cancers and other diseases that can be treated with bone marrow transplantation. She participates in research collaborations at the local level with the OHSU Knight Cancer Institute and at the national and international level with cooperative groups such as the Children's Oncology Group, Pediatric Blood and Marrow Transplant Consortium, Bone Marrow Transplant Clinical Trials Network and the Center for International Blood and Marrow Transplant Research. A variety of clinical trials are available for bone marrow transplant patients at Doernbecher.

Areas of current research include: 
Transplant regimens for pediatric cancers Transplant regimens for immunodeficiency syndromes, genetic diseases and inherited blood disorders Umbilical cord blood transplantation Nonmyeloablative and reduced-intensity regimens of transplantation Prevention and treatment of transplant complications long-term outcomes of marrow transplantation.


  • B.S., 1992, University of Puerto Rico
  • M.D., 1996, University of Puerto Rico School of Medicine
  • M.S., 2004, University of Washington
  • M.B.A., 2013, Oregon Health & Science University
  • Residency:

    • Pediatrics, Rainbow Babies and Children’s Hospital, Case Western Reserve University, 1999
  • Fellowship:

    • Pediatric hematology/oncology, Fred Hutchinson Cancer Research Center, University of Washington, 2002
  • Certifications:

    • National Board of Medical Examiners, 1997
    • American Board of Pediatric Subspecialties, Pediatrics (2000)
    • Pediatric Hematology/Oncology (2004)

Memberships and associations

  • American Society of Pediatric Hematology/Oncology
  • American Society of Hematology
  • American Society of Transplantation & Cellular Therapy
  • International Society of Cell & Gene Therapy

Areas of interest

  • Graft vs. host disease
  • Diversity and Healthcare Disparities
  • Cellular therapies



  • {{ pub.journalAssociation.journal.name.text[0].value }}
    1. {{ person.name.firstName }} {{ person.name.lastName }}